We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
CytoSMART Raises 5.2 Million Euros for Further Product Innovation and Growth
Product News

CytoSMART Raises 5.2 Million Euros for Further Product Innovation and Growth

CytoSMART Raises 5.2 Million Euros for Further Product Innovation and Growth
Product News

CytoSMART Raises 5.2 Million Euros for Further Product Innovation and Growth

CytoSMART Omni - The world’s smallest live-cell imager

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "CytoSMART Raises 5.2 Million Euros for Further Product Innovation and Growth"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

CytoSMART, the Eindhoven-based company that develops and manufactures digital microscopes for monitoring live cell cultures, has received 5.2 million Euros to fund the growth of their business. New investor Eindhoven Venture Capital Fund II joined existing investors Holland Capital and BOM Brabant Ventures. The funding will be used by CytoSMART to further develop its microscopes and to expand its international sales and marketing strategies. CytoSMART has created three highly innovative microscopes that scientists can use to digitally and remotely count, screen, check, and film their cell cultures.

CytoSMART’s latest microscope is the Omni, the world’s fastest live-cell imager. The company has also created a wide range of options for using the collected images to conduct experiments in its own cloud service. The additional funding will be used for product innovation, expanding product functions, and upscaling the company’s international sales and marketing.

“Since the series A round in 2016, our sales have shot up by over 300 percent,” says Joffry Maltha, CEO of CytoSMART. “In order to continue growing, it is important that we keep innovating with our products and increase our investment in marketing and sales activities in the next few years. That means we will be focusing strongly on new image-analysis applications and continued hardware development.”
Advertisement